Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density

Henry G. Bone*, Michael R. McClung, Christian Roux, Robert R. Recker, John A. Eisman, Nadia Verbruggen, Carolyn M. Hustad, Carolyn DaSilva, Arthur C. Santora, B. Avery Ince

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)937-947
JournalJournal of Bone and Mineral Research
Volume25
Issue number5
DOIs
Publication statusPublished - May 2010

Keywords

  • BONE MINERAL DENSITY
  • CATHEPSIN K
  • CLINICAL TRIAL
  • ODANACATIB
  • OSTEOPOROSIS
  • PHASE 2B
  • POSTMENOPAUSAL WOMEN

Cite this